G Blaskó

808 total citations
42 papers, 670 citations indexed

About

G Blaskó is a scholar working on Hematology, Surgery and Internal Medicine. According to data from OpenAlex, G Blaskó has authored 42 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Surgery and 9 papers in Internal Medicine. Recurrent topics in G Blaskó's work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). G Blaskó is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (11 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). G Blaskó collaborates with scholars based in Hungary, Mexico and India. G Blaskó's co-authors include Dénes Bánhegyi, Raymund Machovich, János Jakó, G. Sas, Géza Sas, Gyula Domján, Zsuzsanna Nagy, John H. Griffin, Anna Borsodi and István Hermecz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical Journal and Thrombosis and Haemostasis.

In The Last Decade

G Blaskó

38 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Blaskó Hungary	15	338	130	121	112	106	42	670
ML Rand Canada	13	314 0.9×	87 0.7×	58 0.5×	131 1.2×	53 0.5×	20	615
J. Vermylen Belgium	18	336 1.0×	195 1.5×	102 0.8×	183 1.6×	175 1.7×	59	983
J Hauert Switzerland	16	332 1.0×	177 1.4×	152 1.3×	317 2.8×	234 2.2×	37	973
R. Pescador Italy	14	191 0.6×	118 0.9×	65 0.5×	118 1.1×	59 0.6×	56	654
James McKenney United States	9	206 0.6×	136 1.0×	38 0.3×	75 0.7×	62 0.6×	17	652
HP Schwarz Austria	15	489 1.4×	108 0.8×	105 0.9×	92 0.8×	34 0.3×	40	962
H. J. Reimers Canada	12	304 0.9×	67 0.5×	47 0.4×	160 1.4×	39 0.4×	23	567
Kjell Sverre Galdal Norway	11	218 0.6×	59 0.5×	48 0.4×	58 0.5×	76 0.7×	14	462
María Eugenia de la Morena‐Barrio Spain	16	458 1.4×	86 0.7×	145 1.2×	89 0.8×	95 0.9×	67	798
Mustafa Altınbaş Türkiye	12	111 0.3×	103 0.8×	268 2.2×	158 1.4×	69 0.7×	47	670

Countries citing papers authored by G Blaskó

Since Specialization

Citations

This map shows the geographic impact of G Blaskó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Blaskó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Blaskó more than expected).

Fields of papers citing papers by G Blaskó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Blaskó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Blaskó. The network helps show where G Blaskó may publish in the future.

Co-authorship network of co-authors of G Blaskó

This figure shows the co-authorship network connecting the top 25 collaborators of G Blaskó. A scholar is included among the top collaborators of G Blaskó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Blaskó. G Blaskó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagy, Zsuzsanna, et al.. (2012). D-Dimer as a Potential Prognostic Marker. Pathology & Oncology Research. 18(3). 669–674. 26 indexed citations

Blaskó, G, et al.. (2009). Clinical Research in Hungary. Infrastructure, Organisation, Legislation and Framework. The Situation in 2008. Therapies. 64(1). 33–45.

Nagy, Zsuzsanna, et al.. (2009). The Effect of LMWH (Nadroparin) on Tumor Progression. Pathology & Oncology Research. 15(4). 689–692. 17 indexed citations

Nagy, Béla, Éva Csongrádi, Harjit Pal Bhattoa, et al.. (2007). Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thrombosis and Haemostasis. 98(7). 186–191. 14 indexed citations

Balla, József, Mária Tünde Magyar, Dániel Bereczki, et al.. (2006). Serum Levels of Platelet Released CD40 Ligand Are Increased in Early Onset Occlusive Carotid Artery Disease. Disease Markers. 22(3). 133–140. 21 indexed citations

Pál, András, et al.. (2004). [Microcirculatory changes in patients with chronic venous and lymphatic insufficiency and heavy leg symptoms before and after therapy with procyanidol oligomers (laser-Doppler study)].. PubMed. 145(22). 1177–81. 3 indexed citations

Romics, Imre, et al.. (2003). The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones. British Journal of Urology. 92(1). 92–96. 39 indexed citations

Rák, Kálmán, et al.. (2003). [Conclusions of consensus development conferences on the prevention and treatment of venous thromboembolism].. PubMed. 144(29). 1427–31. 1 indexed citations

Oláh, László, János Kappelmayer, Éva Ajzner, et al.. (2001). Natural Coagulation Inhibitor Proteins in Young Patients with Cerebral Ischemia. Cerebrovascular Diseases. 12(4). 291–297. 7 indexed citations

10.

Salamon, Á, et al.. (1999). [The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis].. PubMed. 140(42). 2339–43. 18 indexed citations

11.

Blaskó, G, A. K. Pal, Neeraj Das, & Lalit M. Srivastava. (1999). Differences in the platelet proaggregatory activity of immune complexes isolated from patients with myocardial infarction or pulmonary cancer. Platelets. 10(2). 105–109. 1 indexed citations

12.

Oláh, László, et al.. (1998). Monocytes Express Tissue Factor in Young Patients with Cerebral Ischemia. Cerebrovascular Diseases. 8(4). 235–239. 11 indexed citations

13.

Boda, Z, et al.. (1996). Low Molecular Weight Heparin as Thromboprophylaxis in Familial Thrombophilia during the Whole Period of Pregnancy. Thrombosis and Haemostasis. 76(1). 128–128. 17 indexed citations

14.

Krämer, J, Katalin Rajczy, László Hegyi, et al.. (1994). C4B*Q0 allotype as risk factor for myocardial infarction. BMJ. 309(6950). 313–314. 32 indexed citations

15.

Boer, Nanne K.H. de, et al.. (1993). Investigations of indomethacin-induced gastric ulcer in rats.. PubMed. 43(7). 767–71. 38 indexed citations

16.

Ezban, Mirella, et al.. (1990). Purification and characterisation of the pathological antithrombin III “Aalborg”. Thrombosis Research. 57(5). 807–812. 2 indexed citations

17.

Bedi, John F., et al.. (1979). The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.. PubMed. 29(9). 1405–8. 1 indexed citations

18.

Blaskó, G & Raymund Machovich. (1979). Decreased Heparin Sensitivity of Cyclohexanedione-Modified Factor Xa. Thrombosis and Haemostasis. 42(2). 556–563. 5 indexed citations

19.

Blaskó, G, et al.. (1978). Air reoxidation and reactivation of reduced thrombin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 51(3). 299–303. 1 indexed citations

20.

Machovich, Raymund, G Blaskó, & Péter Arányi. (1975). The interaction of thrombin and heparin. Heat inactivation kinetics. Thrombosis Research. 7(2). 253–260. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact